Hongchang International Co. Ltd (OTC Pink: HCIL) is a food company that operates through Fuqing Hongchang Food Co., Ltd., its primary operating entity based in Chengtou Town, Fuqing City, Fujian Province, China. Revenue comes from selling food products, with cost of revenue consisting mainly of raw material and prepackaged product purchases. The company was incorporated in Nevada on May 18, 1987, originally as Heyu Biological Technology Corporation, and the operating entity was established in September 2017. Hongchang Global Investment Holdings Limited, the intermediate holding entity, was incorporated in the British Virgin Islands in January 2023. As of March 28, 2025, the company had 724 holders of record of its common stock, with directors and officers controlling approximately 90.9% of shares. The stock trades on the OTC Pink Market at $0.155 per share as of March 27, 2025, classifying it as a penny stock under SEC Rule 15g-9. The company has not paid dividends and does not intend to do so.
- Revenue model
- Transactional product sales of food items. Gross profit equals revenue minus cost of revenue, which consists primarily of raw material and prepackaged product purchases. The company offers competitive pricing to attract and retain customers.
- Products and services
- Food products sold through the operating entity Fuqing Hongchang Food Co., Ltd. The filing references raw materials and prepackaged products as the primary cost inputs but does not specify individual product names or brands.
- Customers and end markets
- The filing does not disclose specific customer names, customer counts, or end market details beyond general food product sales.
- Value-chain role
- Product seller sourcing from external suppliers. The company purchases raw materials and prepackaged goods from suppliers and resells them, with gross margin subject to supplier pricing fluctuations and product mix.
- Geographic exposure
- Operations conducted in Fuqing City, Fujian Province, China through subsidiary Fuqing Hongchang Food Co., Ltd. The parent company is incorporated in Nevada, with an intermediate holding entity in the British Virgin Islands. Subject to PRC regulatory oversight including potential CSRC filing requirements for future overseas offerings.
Source: SEC 10-K, filed 2025-03-28
Industry:
Electromedical & Electrotherapeutic Apparatus
Peers:
Jin Medical International Ltd